Summary
The β-lactamases of Branhamella catarrhalis Ravasio and strain 1908 were readily inhibited by low concentrations of sulbactam, β-halopenicillanic acids, MM 13902 and clavulanic acid. More detailed studies on the interaction of the Ravasio β-lactamase with clavulanic acid demonstrated that the enzyme had high affinity for the inhibitor (Ki= 0.07 µmol/L) and was rapidly inhibited (t½ = 21 sec, kinhib. = 0.033/sec). Two types of enzyme-inhibitor complex were formed, a transiently stable species (t½ = 5.3 minutes at pH 7.3 and 37°C) and a more stable species (t½ ≈ 2 hours at pH 7.3 and 37°C). Irreversible inactivation of the enzyme was not achieved.
Permeability studies on whole cells showed that β-lactam antibiotics and β-lactamase inhibitors readily penetrated the outer membrane of B. catarrhalis.
Similar content being viewed by others
References
Bluestone CD. Augmentin therapy for acute otitis media in children: summary of presentations from four clinical trials. Postgraduate Medicine: Custom Communications. Perspectives and progress on β-lactamase inhibition, pp. 137–139, 1984
Buu Hoi-Dang Van A, Brive-Le Bouguenec C, Barthelemy M, Labia R. Novel β-lactamase from Branhamella catarrhalis. Annales de Microbiologie 129B: 397–406, 1978
Elliason I, Kamme C. Characterisation of the plasmid-mediated β-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. Journal of Antimicrobial Chemotherapy 15: 139–149, 1985
Farmer T, Reading C. β-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrobial Agents and Chemotherapy 21: 506–508, 1982
Fisher J, Charnas RL, Knowles JR. Kinetic studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid. Biochemistry 17: 2180–2184, 1978
Hood JD, Box SJ, Verrall MS. Olivanic acids, a family of β-lactam antibiotics with β-lactamase inhibiting properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus. Journal of Antibiotics 32: 295–304, 1979
Labia R, Lelievre V, Peduzzi J. Inhibition kinetics of three R-factor mediated β-lactamases by a new β-lactam sulfone (CP 45899). Biochemica et Biophysica Acta 611: 351–357, 1980
Mehtar S. Respiratory tract infections caused by β-lactamase producing organisms treated with Augmentin. Scottish Medical Journal 27: S24–S27, 1982
Nikaido H. Nonspecific transport through the outer membrane. In Inouye (Ed) Bacterial outer membranes, pp 361–407, John Wiley and Sons, New York, 1979
Nikaido H, Rosenburg EY, Foulds J. Porin channels in Escherichia coli: studies with β-lactams in intact cells. Journal of Bacteriology 153: 232–240, 1983
Ninane G, Joly J, Kraytman M, Piot P. Bronchopulmonary infection due to β-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic acid. Lancet 2: 257, 1978
Percival A, Corkhill JE, Rowlands J, Sykes RB. Pathogenicity of and β-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet 2: 1175, 1977
Reading C, Cole M. Clavulanic acid: a β-lactamase-inhibiting β-lactam from Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy 11: 852–857, 1977
Reading C, Farmer T. The inhibition of periplasmic β-lactamase in E. coli by clavulanic acid and other β-lactamase inhibitors. Postgraduate Medicine: Custom Communications. Perspectives and progress on β-lactamase inhibition, pp. 163–167, 1984
Simpson IN, Plested SJ. The origin and properties of β-lactamase satellite bands seen in isoelectric focusing. Journal of Antimicrobial Chemotherapy 12: 127–131, 1983
Stobberingh EE, Davies BI, van Boven CPA. Branhamella catarrhalis: antibiotic sensitivities and β-lactamases. Journal of Antimicrobial Chemotherapy 13: 55–64, 1984
Wald ER, Reilly JS, Casselbrandt MC, Chipanis DM. Treatment of acute sinusitus in children: Augmentin vs cefaclor. Postgraduate Medicine: Custom Communications. Perspectives and progress on β-lactamase inhibition, pp. 133–136, 1984
Zimmerman W, Rósselet A. Function of the outer membrane of Escherichia coli as a permeability barrier to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 12: 368–372, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farmer, T., Reading, C. Inhibition of the β-Lactamases of Branhamella catarrhalis by Clavulanic Acid and Other Inhibitors. Drugs 31 (Suppl 3), 70–78 (1986). https://doi.org/10.2165/00003495-198600313-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600313-00015